A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

556

Participants

Timeline

Start Date

April 9, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions

OverweightObesity

Interventions

DRUG

HRS-7535 Tablets

HRS-7535 tablets.

DRUG

HRS-7535 Placebo Tablets

HRS-7535 placebo tablets.

Trial Locations (1)

Chinese PLA General Hospital, Beijing

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY